Skip to content

Deshydroxyethoxy Ticagrelor-d7

Deshydroxyethoxy Ticagrelor-d7

Product Description
CAT No.
ALN-T023D02
CAS No.
NA
Mol. F.
C21H17D7F2N6O3S
Mol. Wt.
485.6
Stock
Please Inquire
RFQ
Chemical Name : (1S,2R,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-((propyl-d7)thio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol
Smiles : FC1=C(F)C=CC([C@H]2[C@@H](C2)NC3=NC(SC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=NC4=C3N=NN4[C@H](C[C@H](O)[C@H]5O)[C@@H]5O)=C1
Inchi : InChI=1S/C6H9N3O3/c1-4-7-5(8-12)6(11)9(4)2-3-10/h10,12H,2-3H2,1H3/b8-5+

Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method

By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.

Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies

By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724

Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)

By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42

Request For Quotation

Related Products